Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (8)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (9)

Article Type

ARVO Annual Meeting Abstract (8)
Immunology and Microbiology (1)

Topics

Cornea (1)
Eye Anatomy and Disorders (1)
Immunology and Microbiology (1)

Tags

cd80 antigens (1)
cornea (1)
eye (1)
human herpesvirus 1 (1)
infections (1)
mice (1)
pathogenicity (1)
stromal keratitis (1)
viruses (1)

Specify Date Range

From: To: Apply

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Role of macrophage sub-populations in ocular HSV-1 infection.

Ujjaldeep Jaggi; Harry Matundan; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):860. doi:

ARVO Annual Meeting Abstract June 2022

The role of CD80 and HSV-1 ICP22 interaction on HSV-1 pathogenicity and latency-reactivation in infected mice

Harry Matundan; Ujjaldeep Jaggi; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1667 – A0497. doi:

ARVO Annual Meeting Abstract June 2022

Small non-coding RNA (sncRNA1) within latency associated transcript (LAT) modulates HSV-1 virulence and host immune response during acute but not latent infection

Kati Tormanen; Harry Matundan; Ujjaldeep Jaggi; Shaohui Wang; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1665 – A0495. doi:

ARVO Annual Meeting Abstract June 2021

The suppressive effect of ICP22 on CD80 promoter is altered by a recombinant virus lacking CD80 binding site

Harry Matundan; Shaohui Wang; Ujjaldeep Jaggi; Jack Yu; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):419. doi:

ARVO Annual Meeting Abstract June 2021

Effect of further shifting the M2-like macrophage responses by cellular adjuvant on primary and latent HSV-1 infection

Ujjaldeep Jaggi; Harry Matundan; Jack Yu; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1966. doi:

Immunology and Microbiology August 2019

Loss of ICP22 in HSV-1 Elicits Immune Infiltration and Maintains Stromal Keratitis Despite Reduced Primary and Latent Virus Infectivity

PDF

Harry H. Matundan; Ujjaldeep Jaggi; Shaohui Wang; Homayon Ghiasi
TAGS: eye, human herpesvirus 1, mice, viruses, stromal keratitis, pathogenicity, cornea, cd80 antigens, infections
Invest. Ophthalmol. Vis. Sci.. 2019; 60(10):3398-3406. doi: https://doi.org/10.1167/iovs.19-27701

ARVO Annual Meeting Abstract July 2019

Suppression of CD80 in the eye by HSV-1 ICP22 plays a protective role against eye disease

Harry Matundan; Ujjaldeep Jaggi; Shaohui Wang; Homayon Ghiasi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4620. doi:

ARVO Annual Meeting Abstract June 2017

Role of CD8 + T cells versus CD8α + DCs in HSV-1 latency-reactivation

Homayon Ghiasi; Kevin R Mott; Sariah J Allen; Yasamin N Ghiasi; Harry Matundan; Terrence Town

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2986. doi:

ARVO Annual Meeting Abstract September 2016

Interrelationship of primary virus replication in the eye, level of latency and time to reactivate in the trigeminal ganglia (TG) of latently infected mice

Homayon Ghiasi; Kevin Mott; Sariah Allen; Yasamin Ghiasi; Terrence Town; Steven Wechsler; Harry Matundan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2334. doi:

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept